Diversified Healthcare Trust (DHC)
NASDAQ: DHC · Real-Time Price · USD
2.560
-0.020 (-0.78%)
Nov 13, 2024, 4:00 PM EST - Market closed

Company Description

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States.

DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.

As of December 31, 2023, DHC’s approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units.

DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate.

DHC is headquartered in Newton, MA.

Diversified Healthcare Trust
Diversified Healthcare Trust logo
Country United States
Founded 1998
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 600
CEO Christopher Bilotto

Contact Details

Address:
Two Newton Place, 255 Washington Street, Suite 300
Newton, Massachusetts 02458-1634
United States
Phone 617 796 8350
Website dhcreit.com

Stock Details

Ticker Symbol DHC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001075415
CUSIP Number 25525P107
ISIN Number US25525P1075
Employer ID 04-3445278
SIC Code 6798

Key Executives

Name Position
Christopher J. Bilotto President, Chief Executive Officer and Managing Trustee
Adam David Portnoy Managing Chair of the Board
Matthew C. Brown Chief Financial Officer and Treasurer
Kevin Brady Director of Investor Relations
David M. Blackman Director of Acquisition
Jennifer Babbin Clark Secretary
Melissa Mccarthy Manager of Investor Relations

Latest SEC Filings

Date Type Title
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 4, 2024 10-Q Quarterly Report
Nov 4, 2024 8-K Current Report
Oct 22, 2024 SCHEDULE 13G/A Filing
Oct 9, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Aug 1, 2024 10-Q Quarterly Report
Aug 1, 2024 8-K Current Report
Jun 28, 2024 EFFECT Notice of Effectiveness
Jun 25, 2024 UPLOAD Filing
Jun 21, 2024 DEL AM Filing